PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Oral Oncology10.1016/j.oraloncology.2016.06.01320166018-24Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinomaLixia Lu, Jiaxin Li, Chong Zhao, Wenqiong Xue, Fei Han, Tang Tao, Hui Chang, Weihua Jia, Taixiang Luhttps://api.elsevier.com/content/article/PII:S1368837516300872?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S1368837516300872?httpAccept=text/xml
Cancer Research and Treatment10.4143/crt.2017.2372018503861-871Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort StudyQiu-Yan Chen, Shao-Yan Guo, Lin-Quan Tang, Tong-Yu Lu, Bo-Lin Chen, Qi-Yu Zhong, Meng-Sha Zou, Qing-Nan Tang, Wen-Hui Chen, Shan-Shan Guo, Li-Ting Liu, Yang Li, Ling Guo, Hao-Yuan Mo, Rui Sun, Dong-Hua Luo, Chong Zhao, Ka-Jia Cao, Chao-Nan Qian, Xiang Guo, Mu-Sheng Zeng, Hai-Qiang Maihttp://e-crt.org/upload/pdf/crt-2017-237.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2017.237, http://www.e-crt.org/upload/pdf/crt-2017-237.pdf
Frontiers in Oncology10.3389/fonc.2020.00356202010Clinical Implications of Plasma Epstein–Barr Virus DNA in Children and Adolescent Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated RadiotherapyWenze Qiu, Xing Lv, Xiang Guo, Yawei Yuanhttps://www.frontiersin.org/article/10.3389/fonc.2020.00356/full
Frontiers in Oncology10.3389/fonc.2020.600429202110Exploring the Optimal Chemotherapy Strategy for Locoregionally Advanced Children and Adolescent Nasopharyngeal Carcinoma Based on Pretreatment Epstein-Barr Virus DNA Level in the Era of Intensity Modulated RadiotherapyZiyi Zeng, Chen Chen, Lanlan Guo, Cheng Zhang, Lei Chen, Chuanping Yuan, Lixia Luhttps://www.frontiersin.org/articles/10.3389/fonc.2020.600429/full
Cancer Management and Research10.2147/cmar.s2397292020Volume 12957-963

Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review

Peng Wu, Yumei Zhao, Li Xiang, Linglin Yanghttps://www.dovepress.com/getfile.php?fileID=55961, https://www.dovepress.com/getfile.php?fileID=55961
Annals of Oncology10.1093/annonc/mdy438.015201829ix98The efficacy of induction chemotherapy in stage II nasopharyngeal carcinoma in the intensity modulated radiotherapy (IMRT) eraP.-J. Lihttps://api.elsevier.com/content/article/PII:S0923753419432912?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419432912?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/29/suppl_9/mdy438.015/26699208/mdy438.015.pdf
Cancer Management and Research10.2147/cmar.s3110942021Volume 136799-6810Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy EraQian Li, Lushi Yu, Pengcheng Yang, Qinyong Huhttps://www.dovepress.com/getfile.php?fileID=73186, https://www.dovepress.com/getfile.php?fileID=73186
Head & Neck10.1002/hed.2665420214361838-1847Nomograms for predicting survival outcomes in intensity‐modulated radiotherapy era of nasopharyngeal carcinoma: A study based on Epstein – Barr virus DNA biological responsesKaixuan Yang, Mei Li, Jinbing Zhu, Lei Zeng, Jiangfang Tian, Wenji Xie, Arthur Shou, Yiping Li, Guangjun Lihttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26654, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/hed.26654, https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26654
OncoTargets and Therapy10.2147/ott.s1404202017Volume 103329-3336Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinomaFen Xue, Chaosu Hu, Xiayun Hehttps://www.dovepress.com/getfile.php?fileID=37289, https://www.dovepress.com/getfile.php?fileID=37289
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2015.10.04220169416A Prognostic Analysis on Using the Combination of Tumor Volume and Epstein-Barr Virus DNA in Patients With Nasopharyngeal Carcinoma Treated With IMRTL. Lu, J. Li, W. Jia, C. Zhao, T. Luhttps://api.elsevier.com/content/article/PII:S0360301615266370?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301615266370?httpAccept=text/plain